Non-organ-specific autoantibodies in chronic hepatitis C patients: Association with histological activity and fibrosis

Journal of Autoimmunity

Volumn 32, Issue 3-4, 2009, Pages 201-205

  Chretien P ^a   Chousterman, M ^a   Alsamad, I Abd ^a   Ozenne, V ^a   Rosa, I ^a   Barrault, C ^a   Lons, T ^a   Hagege H ^a  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

Autoantibodies; Chronic hepatitis C; HCV infection; Histology; Liver fibrosis

Indexed keywords

ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; F ACTIN; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LIVER CYTOSOL1 ANTIBODY; MICROSOME ANTIBODY; MITOCHONDRION ANTIBODY; SMOOTH MUSCLE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CRYOGLOBULINEMIA; DIABETES MELLITUS; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; SARCOIDOSIS; SIALOADENITIS; THYROIDITIS; VIRUS LOAD;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; AUTOANTIBODIES; FEMALE; GAMMA-GLOBULINS; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED;

EID: 67349095042     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.02.005     Document Type: Article

References (26)

1. Boyer N., and Marcellin P. Pathogenesis, diagnosis and management of hepatitis C. J Hepatol 32 (2000) 98-112
2. Vergani D., Alvarez F., Bianchi F.B., Cançado E.L.R., Mackay I.R., Manns M.P., et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the international autoimmune hepatitis group. J Hepatol 41 (2004) 677-683
3. Clifford B.D., Donahue D., Smith L., Cable E., Luttig B., Manns M., et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21 (1995) 613-619
4. Cassini F., Cateleta M., Valentini P., Muratori P., Giostra F., Francesconi R., et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on disease profile. Hepatology 26 (1997) 561-566
5. Lenzi M., Bellentani S., Sccoccio G., Muratori P., Masutti F., Muratori L., et al. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a case-control study of the Dionysos cohort. Gut 45 (1999) 435-441
6. Gregorio G.V., Pensati P., Iorio R., Vegnente A., Mieli-Vergani G., and Vergani D. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 112 (1998) 471-476
7. Muratori P., Muratori L., Verucchi G., Affard L., Bianchi F.B., and Lenzi M. Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment. Clin Infect Dis 37 (2003) 1320-1326
8. Cacoub P., Renou C., Rosenthal E., Cohen P., Loury I., Loustaud-Ratti V., et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Médecine Interne et Maladies Infectieuses sur le Virus de l'Hépatite C. Medicine (Baltimore) 79 (2000) 47-56
9. Pawlotsky J.M., Ben Yahia M., Andre C., Voisin M.C., Intrator L., Roudot-Thoraval F., et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 19 (1994) 841-848
10. Hsieh M.-Y., Dai C.-Y., Lee L.-P., Huang J.-F., Tsai W.-C., Hou N.-J., et al. The antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in chronic hepatitis C patients. J Clin Pathol 6 (2007) 333-337
11. Stroffolini T., Colloredo G., Gaeta G.B., Sonzogni A., Angeletti S., Marignani M., et al. Does an 'autoimmune' profile affect the clinical profile of chronic hepatitis C? An Italian multicenter survey. J Viral Hepat 11 (2004) 257-262
12. Chretien-Leprince P., Ballot E., Andre C., Olsson N.O., Fabien N., Escande A., et al. Diagnostic value of anti-Factin antibodies in a French multicenter study. Ann NY Acad Sci 1050 (2005) 1-8
13. Bedossa P., and Poynard T. The METAVIR cooperative study group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 24 (1996) 189-193 12
14. Payan C., Roudot-Thoraval F., Marcellin P., Bled N., Duverlie G., Fouchard-Hubert I., et al. Changing of hepatitis C virus genotype patterns in France at the beginning of the third millennium: the GEMHEP GenoCII Study. J Viral Hepat 12 (2005) 405-413
15. Roudot-Thoraval F., Bastie A., Pawlotsky J.M., and Dhumeaux D. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology 26 (1997) 485-490
16. Garcia-Buey L., Garcia-Monzon C., Rodriguez S., Borque M.J., Garcia-Sanchez A., and Iglesias R. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 108 (1995) 1770-1777
17. Muratori L., Catela M., Giostra F., Cassani F., Ballardini G., Zauli D., et al. Interferon therapy in liver/kidney microsomal antibody type1-positive patients with chronic hepatitis C. J Hepatol 21 (1994) 199-203
18. Wasmuth H.E., Stolte C., Geier A., Dietrich C.G., Gartung C., Lorenzen J., et al. The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C. BMC Infect Dis 4 (2004) 4-12
19. Czaja A.J., Carpenter H., Santrach P.J., and Moore B. DR human leukocyte antigens and disease severity in chronic hepatitis C. J Hepatol 24 (1996) 666-673
20. Luo J.-C., Hwang S.-J., Li C.-P., Lu R.-H., Chan C.-Y., Wu J.-C., et al. Clinical significance of serum auto-antibodies in Chinese patients with chronic hepatitis C: negative role of serum viral titre and genotype. J Gastoenterol Hepatol 13 (1998) 475-479
21. Congia M., Clemente M.G., Dessi C., Cucca F., Mazzoleni A.P., Frau F., et al. HLA class II genes in chronic hepatitis C virus-infection and associated immunologic disorders. Hepatology 24 (1996) 1338-1341
22. Nishioka M., Morshed M.A., Kono K., Himoto T., Parveen S., Amira K., et al. Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C. J Hepatol 26 (1997) 992-1000
23. Muratori P., Muratori L., Stroffolini T., Pappas G., Terlizzi P., Ferrari R., et al. Prevalence of non-organ specific autoantibodies in HCV-infected subjects in the general population. Clin Exp Immunol 131 (2003) 118-121
24. Ferri C., and Bombardieri S. HCV and cryoglobulinemia. In: Shoenfeld Y., and Rose N.R. (Eds). Infection and autoimmunity (2004), Elsevier 201-212
25. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., et al. Binding of hepatitis C virus to CD81. Science 282 (1998) 938-941
26. Marceau G., Lapierre P., Béland K., Soudeyns H., and Alvarez F. LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry?. Hepatology 42 3 (2005) 675-682